Latest Supply Chain Challenges News

Newmont Corporation’s 2024 Annual Report reveals a robust financial performance fueled by higher metal prices and the strategic acquisition of Newcrest Mining. The company also embarks on a major portfolio reshaping with planned divestitures of six non-core assets.

EBOS Group Limited’s interim results for H1 2025 reveal a notable decrease in revenue and profit compared to the prior year, yet the company maintains its interim dividend, signaling confidence despite headwinds.

The a2 Milk Company posted robust first-half FY25 results, lifting revenue by 10.1% and net profit by 7.6%, while introducing a dividend policy for the first time. Strong English label IMF sales and liquid milk growth underpin an upgraded full-year outlook.

Treasury Wine Estates reports a robust first half of 2025, driven by luxury portfolio growth and DAOU integration, while premium segments face headwinds.

Breville Group Limited reported a robust half-year performance with 10.1% revenue growth and a 16.1% rise in net profit, driven by strong coffee category sales and strategic product launches. Despite macroeconomic headwinds and tariff concerns, the company maintains a confident outlook for FY25.

Nick Scali Limited’s half-year results reveal a 30.2% decline in statutory profit, impacted by UK acquisition losses and restructuring costs, yet the company maintains shareholder returns with a fully franked interim dividend.

Sunrise Energy Metals has updated its Syerston Scandium Project Mineral Resource Estimate, confirming a substantial global resource and planning a targeted drilling campaign to expand high-grade zones. The company is advancing product development with key partners amid growing demand for scandium in strategic sectors.

ResMed Inc. reported robust financial results for the quarter ended December 31, 2024, with a 10% increase in net revenue and a 65% jump in net income, driven by strong demand across its Sleep and Breathing Health and Residential Care Software segments.

Nova Eye Medical Limited is raising A$6.6 million to strengthen its financial position following resolved supply chain disruptions, while reporting strong sales growth and nearing profitability in its glaucoma division.

Nova Eye Medical reports a robust 39% increase in global sales driven by strong U.S. market demand and secures $6.6 million in fresh capital to fuel expansion and product development.